Essentia health Inpatient Pharmacy Department, Fargo, ND, USA.
Essentia Institute of Rural Health Education and Research Department, Duluth, MN, USA.
J Pharm Pract. 2024 Aug;37(4):895-899. doi: 10.1177/08971900231189355. Epub 2023 Aug 19.
A pharmacist-led COVID-19 vaccination screening and administration tool was implemented at a tertiary care hospital in the Upper Midwest, allowing pharmacists to determine if an inpatient is a candidate for the COVID-19 vaccination. The purpose of this observational study was to examine the feasibility of a pharmacist-led, COVID-19 vaccination administration workflow to the inpatient population in a tertiary care hospital. This observational study was conducted at an Upper-Midwest facility and includes a study population of adult patients admitted to the hospital between 10/1/2021 - 1/1/2022. The primary outcome of this study was the number of COVID-19 vaccinations administered. Secondary outcomes included the number of attending physician approvals, pharmacist time dedicated to the vaccination program, patient demographics, and patient acceptance of vaccination. Group differences were evaluated using odds ratios, 95% confidence intervals, Pearson's chi-square test, the Mann-Whitney U test, and multivariate logistic regression. There were 715 patients eligible to receive COVID-19 vaccination. Of those, 23 (3.2%) patients received a COVID-19 vaccine while inpatient. After adjusting for sex at birth, age at admission, and length of hospital stay, compared to previously unvaccinated patients, those with their second dose due were 7.3 times more likely to have been given a vaccination (95% CI 1.3-42.1, = 0.026), while patients with their booster due were 4 times more likely to have been given a vaccination (95% CI 1.3-12.3, = 0.014). Although unvaccinated patients were successfully identified, only 23 were able to be vaccinated. Additional barriers need to be addressed to make this program successful.
药剂师主导的 COVID-19 疫苗接种筛选和管理工具在中西部的一家三级保健医院实施,使药剂师能够确定住院患者是否适合接种 COVID-19 疫苗。本观察性研究的目的是检验药剂师主导的 COVID-19 疫苗接种管理工作流程在三级保健医院住院患者中的可行性。本观察性研究在中西部的一家医疗机构进行,研究人群包括 2021 年 10 月 1 日至 2022 年 1 月 1 日期间住院的成年患者。本研究的主要结果是接种的 COVID-19 疫苗数量。次要结果包括主治医生批准的数量、药剂师专门用于疫苗接种计划的时间、患者人口统计学特征以及患者对疫苗接种的接受程度。使用优势比、95%置信区间、皮尔逊卡方检验、曼-惠特尼 U 检验和多变量逻辑回归评估组间差异。有 715 名患者有资格接种 COVID-19 疫苗。其中,23 名(3.2%)住院患者接种了 COVID-19 疫苗。在校正出生时的性别、入院时的年龄和住院时间后,与未接种疫苗的患者相比,第二针疫苗接种的患者接种疫苗的可能性高 7.3 倍(95%CI 1.3-42.1,=0.026),而第三针疫苗接种的患者接种疫苗的可能性高 4 倍(95%CI 1.3-12.3,=0.014)。尽管成功识别了未接种疫苗的患者,但只有 23 名患者能够接种疫苗。需要解决其他障碍,以使该计划取得成功。